HB 483 VA To Executive
Prescription Drug Affordability Board; established.
A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →
Summary
Prescription Drug Affordability Advisory Panel established; maximum fair price; annual reports; civil penalties. Directs the Secretary of Health and Human Resources to establish the Prescription Drug Affordability Advisory Panel to conduct data analyses, develop policy recommendations, and identify implementation barriers related to strategies to improve prescription drug affordability, enhance price transparency, and strengthen data collection practices for prescription drugs across public and private payers. The bill requires the Panel to (i) report annually on prescription drug pricing trends and any policy recommendations on legislation to improve prescription drug affordability and (ii) provide quarterly updates on prescription drug pricing trends. The bill requires each pharmacy benefits manager to provide to the Panel, upon request, certain information relating to the dispensation of a referenced drug, as defined in the bill.The bill prohibits prescription drug manufacturers or wholesale distributors permitted or licensed in the Commonwealth from accepting payment at an amount higher than the maximum fair price established by the U.S. Secretary of Health and Human Services pursuant to federal law for the sale of a referenced drug intended for use by individuals in the Commonwealth. Under the bill, an entity that violates such prohibition is subject to a civil penalty of $10,000 per violation. The bill also prohibits a manufacturer subject to its provisions from removing a referenced drug from sale distribution in the Commonwealth for the purpose of avoiding the impact of the bill's rate limitations without providing certain prior notice. Under the bill, a manufacturer that violates such prohibition on removing a referenced drug without the required notice is subject to a civil penalty equal to the greater of $100,000 or the total amount of annual savings for the referenced drug, as determined by the Board of Pharmacy. This bill is identical to SB 271.
Sponsor (1)
- Karrie K. Delaney Democratic · primary
8 coauthors / cosponsors
- Nadarius E. Clark Democratic · cosponsor
- Ellen H. McLaughlin · cosponsor
- Joshua E. Thomas Democratic · cosponsor
- Kannan Srinivasan Democratic · cosponsor
- Elizabeth R. Guzman Democratic · cosponsor
- Michelle Lopes Maldonado · cosponsor
- Holly M. Seibold Democratic · cosponsor
- Virgil Thornton Democratic · cosponsor
Action history (41)
- Jan 12, 2026 Prefiled and ordered printed; Offered 01-14-2026 26104953D · lower
- Jan 12, 2026 Referred to Committee on Labor and Commerce · lower
- Jan 19, 2026 Assigned HCL sub: Subcommittee #1 · lower
- Jan 27, 2026 House subcommittee offered · lower
- Jan 27, 2026 Subcommittee recommends reporting with amendment(s) and referring to Appropriations (5-Y 4-N) · lower
- Jan 27, 2026 Fiscal Impact Statement from Department of Planning and Budget (HB483) · lower
- Jan 29, 2026 Reported from Labor and Commerce with amendment(s) and referred to Appropriations (14-Y 8-N) · lower
- Jan 30, 2026 Assigned HAPP sub: Health & Human Resources · lower
- Feb 6, 2026 Subcommittee recommends reporting (6-Y 1-N) · lower
- Feb 9, 2026 Reported from Appropriations (17-Y 5-N) · lower
- Feb 11, 2026 Read first time · lower
- Feb 12, 2026 Read second time · lower
- Feb 12, 2026 committee amendments agreed to · lower
- Feb 12, 2026 Engrossed by House as amended · lower
- Feb 13, 2026 Read third time and passed House (61-Y 33-N 0-A) · lower
- Feb 16, 2026 Constitutional reading dispensed (on 1st reading) · upper
- Feb 16, 2026 Referred to Committee on Commerce and Labor · upper
- Feb 17, 2026 Fiscal Impact Statement from Department of Planning and Budget (HB483) · lower
- Mar 9, 2026 Senate committee offered · upper
- Mar 9, 2026 Reported from Commerce and Labor with substitute and rereferred to Finance and Appropriations (12-Y 3-N) · upper
- Mar 9, 2026 Committee substitute printed 26109394D-S1 · upper
- Mar 9, 2026 Reported from Finance and Appropriations with substitute (10-Y 4-N) · upper
- Mar 10, 2026 Committee substitute printed 26109533D-S2 · upper
- Mar 10, 2026 Rules suspended · upper
- Mar 10, 2026 Constitutional reading dispensed (on 2nd reading) (37-Y 0-N 0-A) · upper
- Mar 10, 2026 Passed by for the day (Voice Vote) · upper
- Mar 11, 2026 Read third time · upper
- Mar 11, 2026 Commerce and Labor Substitute rejected · upper
- Mar 11, 2026 Finance and Appropriations Substitute agreed to · upper
- Mar 11, 2026 Engrossed by Senate - committee substitute · upper
- Mar 11, 2026 Passed Senate with substitute (34-Y 6-N 0-A) · upper
- Mar 12, 2026 Senate substitute agreed to by House (87-Y 11-N 0-A) · lower
- Mar 23, 2026 Fiscal Impact Statement from Department of Planning and Budget (HB483) · lower
- Mar 30, 2026 Enrolled · lower
- Mar 30, 2026 Bill text as passed House and Senate (HB483ER) · lower
- Mar 30, 2026 Signed by President · upper
- Mar 31, 2026 Fiscal Impact Statement from Department of Planning and Budget (HB483) · lower
- Mar 31, 2026 Signed by Speaker · lower
- Mar 31, 2026 Enrolled Bill communicated to Governor on March 31, 2026 · lower
- Mar 31, 2026 Governor's Action Deadline 11:59 p.m., April 13, 2026 · executive
- Apr 13, 2026 Governor's recommendation received by House · executive
Text versions (18)
The published texts of this bill as it moves through the legislature. Each links to the official document on the state legislature site. Data from OpenStates.
- Governor Substitute · PDF
- Governor Substitute · HTML
- Governor's Recommendation · HTML
- Enrolled · PDF
- Enrolled · HTML
- Finance and Appropriations Substitute · PDF
- Finance and Appropriations Substitute · HTML
- Commerce and Labor Substitute · PDF
- Commerce and Labor Substitute · HTML
- Commerce and Labor Substitute · PDF
- Commerce and Labor Substitute · HTML
- Engrossed · PDF
- Engrossed · HTML
- Labor and Commerce Amendment · HTML
- Labor and Commerce Amendment · HTML
- Subcommittee #1 Subcommittee Amendment · HTML
- Introduced · PDF
- Introduced · HTML
Full text
The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.
Comments
Data from OpenStates. View on OpenStates →
Comments